Welcome to LookChem.com Sign In|Join Free

CAS

  • or

89151-44-0

Post Buying Request

89151-44-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89151-44-0 Usage

Description

1-Boc-4-(2-hydroxyethyl)piperidine, also known as N-BOC-4-piperidine-β-ethanol, is an organic compound that serves as an important intermediate in the synthesis of various pharmaceuticals and bioactive molecules. It features a piperidine ring with a 2-hydroxyethyl side chain and a Boc-protecting group, which plays a crucial role in the compound's reactivity and stability during chemical reactions.

Uses

Used in Pharmaceutical Industry:
1-Boc-4-(2-hydroxyethyl)piperidine is used as a key intermediate for the preparation of anilinoquinazoline VEGF receptor tyrosine kinase inhibitors. These inhibitors possess antitumor activities and are valuable in the development of cancer therapeutics. 1-Boc-4-(2-hydroxyethyl)piperidine's unique structure allows for the design of molecules that can effectively target and inhibit the VEGF receptor, thereby disrupting angiogenesis and limiting tumor growth.
Additionally, 1-Boc-4-(2-hydroxyethyl)piperidine is used as a synthetic precursor for the development of 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. These antagonists exhibit antiviral activities and are particularly useful in the treatment of viral infections, such as HIV. 1-Boc-4-(2-hydroxyethyl)piperidine's versatility in synthesis enables the creation of molecules that can selectively target the CCR5 receptor, thus modulating the immune response and preventing viral entry into host cells.

Check Digit Verification of cas no

The CAS Registry Mumber 89151-44-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,1,5 and 1 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 89151-44:
(7*8)+(6*9)+(5*1)+(4*5)+(3*1)+(2*4)+(1*4)=150
150 % 10 = 0
So 89151-44-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H23NO3/c1-12(2,3)16-11(15)13-7-4-10(5-8-13)6-9-14/h10,14H,4-9H2,1-3H3

89151-44-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (547247)  N-Boc-4-piperidineethanol  97%

  • 89151-44-0

  • 547247-1G

  • 521.82CNY

  • Detail
  • Aldrich

  • (547247)  N-Boc-4-piperidineethanol  97%

  • 89151-44-0

  • 547247-5G

  • 1,800.63CNY

  • Detail

89151-44-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Boc-4-(2-hydroxyethyl)piperidine

1.2 Other means of identification

Product number -
Other names tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89151-44-0 SDS

89151-44-0Relevant articles and documents

Sustainable Route Toward N-Boc Amines: AuCl3/CuI-Catalyzed N-tert-butyloxycarbonylation of Amines at Room Temperature

Cao, Yanwei,He, Lin,Huang, Yang

, (2021/12/22)

N-tert-butoxycarbonyl (N-Boc) amines are useful intermediates in synthetic/medicinal chemistry. Traditionally, they are prepared via an indirect phosgene route with poor atom economy. Herein, a step- and atom-economic synthesis of N-Boc amines from amines, t-butanol, and CO was reported at room temperature. Notably, this N-tert-butyloxycarbonylation procedure utilized ready-made substrates, commercially available AuCl3/CuI as catalysts, and O2 from air as the sole oxidant. This catalytic system provided unique selectivity for N-Boc amines in good yields. More significantly, gram-scale preparation of medicinally important N-Boc amine intermediates was successfully implement, which demonstrated a potential application prospect in industrial syntheses. Furthermore, this approach also showed good compatibility with tertiary and other useful alcohols. Investigations of the mechanisms revealed that gold catalyzed the reaction and copper acted as electron transfer mediator in the catalytic cycle.

Synthesis and J-Dimer Formation of Tetrapyrazinoporphyrazines with Different Functional Groups for Potential Biomolecular Probe Applications

Demuth, Jiri,Kantor, Michal,Machan, Matej,Miletin, Miroslav,Novakova, Veronika,Zimcik, Petr

, p. 527 - 537 (2020/04/07)

Though tetrapyrazinoporphyrazines (TPyzPzs) are generally presented as universal dark quenchers for oligonucleotide probes, the availability of TPyzPzs bearing different functional groups suitable for attachment to 3′, and 5′ ends or intrastrand positions remains rather limited. Therefore, a synthetic route to hexa(bis(2-methoxyethyl)amino) or hexa(diethylamino) TPyzPzs functionalized by an azide, hydroxy, or carboxy group or their combinations was developed. Studies of self-assembly into J-dimers in nonpolar solvents and their stability upon titration with pyridine (association constants, KP values, ranging 0.32–12.7×102 M?1) revealed that smaller peripheral substituents and functionalization of TPyzPzs improves the stability of J-dimers. ΦΔ and ΦF were low for the monomers (ΦFΔF=0.027, ΦΔ=0.28).

Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)

Wang, Wentian,Zhang, Lu,Morlock, Lorraine,Williams, Noelle S.,Shay, Jerry W.,De Brabander, Jef K.

supporting information, p. 5217 - 5241 (2019/05/28)

Despite advances in targeted anticancer therapies, there are still no small-molecule-based therapies available that specifically target colorectal cancer (CRC) development and progression, the second leading cause of cancer deaths. We previously disclosed the discovery of truncating adenomatous polyposis coli (APC)-selective inhibitor 1 (TASIN-1), a small molecule that specifically targets colorectal cancer cells lines with truncating mutations in the adenomatous polyposis coli (APC) tumor suppressor gene through inhibition of cholesterol biosynthesis. Here, we report a medicinal chemistry evaluation of a collection of TASIN analogues and activity against colon cancer cell lines and an isogenic cell line pair reporting on the status of APC-dependent selectivity. A number of potent and selective analogues were identified, including compounds with good metabolic stability and pharmacokinetic properties. The compounds reported herein represent a first-in-class genotype-selective series that specifically target apc mutations present in the majority of CRC patients and serve as a translational platform toward a targeted therapy for colon cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 89151-44-0